IP², an initiative of the Hoover Institution at Stanford University, last week hosted a more than 60 IP scholars, economists and practitioners to hear and challenge research
IP², an initiative of the Hoover Institution at Stanford University, last week hosted a more than 60 IP scholars, economists and practitioners to hear and challenge research
The use of inaccurate, prejudicial language by newspapers, business publications and technology magazines to describe patent licensing activity biases readers and courts. That is among
The eagerly sought bottom for publicly traded patent licensing companies may have been reached according to the data provided by an intellectual property index that
Of the top eleven active US patent holders, only four are American companies. But who gets the best return on their innovation rights is less
Most patent holders would agree that licensing patents for revenue has gone from bad to awful — from difficult less than a decade ago, to
A California jury has awarded pharmaceutical drug company Merck $200 million, a fraction of what it had sought, for infringement of two of its patents
While many high-tech patents are suffering from devaluation the value of some pharmaceutical patents is soaring. Merck & Co. won a legal victory over
The Eastern District of Texas (E.D. Tx.) is responsible for almost half of all patent suits filed in 2015, and one judge, Rodney Gilstrap, is
Valencia Martin Wallace, Deputy Commissioner for Patent Quality at the United States Patent and Trademark Office, will deliver the keynote address at the USPTO’s Enhanced
In an information age that worships data and transparency, the trade or business secret has never been more valuable. “Secrets” is an essential guide to
While it may seem like all of the patent infringement targets are large technology companies in 2015, at least 7 of the top 10 defendants
If it seems like US patent transactions have fallen dramatically over past few years you are not imagining things, says a Chicago patent attorney. According